Frank Zavrl
Direttore/Membro del Consiglio presso CERVOMED INC.
Patrimonio netto: 7 M $ in data 31/05/2024
Profilo
Frank E.
Zavrl is currently a Non-Executive Director at EIP Pharma, Inc. and an Independent Director at CervoMed, Inc. He previously served as an Independent Director at Puma Biotechnology, Inc. from 2015 to 2020 and as a Director at EIP Pharma LLC in 2017 and 2018.
He also worked as an Equity Analyst at Adage Capital Management LP and as an Analyst at Zurich Scudder Investments, Inc. from 1998 to 1999.
Additionally, he was a Portfolio Manager at Merlin Biomed Group LLC from 1999 to 2002.
Mr. Zavrl obtained his undergraduate degree from the University of California, Berkeley and an MBA from the Tuck School of Business at Dartmouth.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CERVOMED INC.
4.28% | 14/06/2024 | 353 009 ( 4.28% ) | 7 M $ | 31/05/2024 |
Posizioni attive di Frank Zavrl
| Società | Posizione | Inizio |
|---|---|---|
| CERVOMED INC. | Direttore/Membro del Consiglio | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Frank Zavrl
| Società | Posizione | Fine |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 06/07/2020 |
| EIP Pharma LLC | Direttore/Membro del Consiglio | 01/03/2018 |
Merlin Biomed Group LLC
 Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City | Corporate Officer/Principal | 01/01/2002 |
| Zurich Scudder Investments, Inc. | Corporate Officer/Principal | 01/01/1999 |
Adage Capital Management LP
 Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts. | Analyst-Equity | - |
Formazione di Frank Zavrl
| University of California, Berkeley | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Aziende private | 5 |
|---|---|
Adage Capital Management LP
Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts. | Finance |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Merlin Biomed Group LLC
Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City | Finance |
| Zurich Scudder Investments, Inc. | Finance |
| EIP Pharma LLC |
- Borsa valori
- Insiders
- Frank Zavrl
